SR One

ADARx is a clinical-stage biotechnology company dedicated to transforming cutting-edge science into next-generation RNA therapeutics to treat a broad spectrum of diseases. Our goa…

Arcellx is focused on achieving cures with cell therapy, specifically through CAR T-cell therapy designed to treat certain kinds of blood cancer. Their process involves engineerin…

Avenzo Therapeutics is committed to improving the lives of cancer patients by developing next-generation oncology therapies that address high unmet medical needs.

CHARM Therapeutics is pioneering a new generation of menin inhibitors for the treatment of Acute Myeloid Leukemia (AML), focusing on overcoming resistance mutations and improving…

Draig Therapeutics is developing transformative, best-in-class neuropsychiatric therapies to restore the brain to a healthier state, enabling patients to live their best lives.

Fore Biotherapeutics is a precision oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat cancers.

Pulmocide is a biopharmaceutical company that specializes in tackling difficult-to-treat respiratory diseases, focusing on respiratory fungal infections. Their lead product, opelc…

River Renal is a clinical-stage company developing novel therapies for orphan renal diseases.

Simcha Therapeutics is a clinical-stage biotechnology company developing novel immunotherapies for cancer, focusing on engineered cytokines to enhance immune responses against tum…

Zenas Biopharma is dedicated to developing transformative therapies for patients with autoimmune diseases, focusing on innovative drug development and commercialization.

Bicycle Therapeutics is developing precision-guided therapeutics to target solid tumors and other hard-to-treat conditions using their proprietary phage display-screening platform.

Details are not available yet. The company remains listed.

Dren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel antibody therapeutics that selectively deplete pathogenic…

HotSpot Therapeutics is pioneering a new approach to allosteric drug discovery by unlocking the on/off switches on proteins called 'natural hotspots' to enable differentiated medi…

Mission Therapeutics is a drug development company focused on treating kidney disease, neurodegenerative diseases, and rare mitochondrial diseases. The company targets the ubiquit…

Nimbus Therapeutics is focused on developing breakthrough medicines through precision small molecule design, emphasizing selectivity in drug discovery and clinical development.

Nomic was founded to make biology easier to measure and enable scientists to extend lives by making proteomics accessible, scalable, and routine. Powered by its proprietary nELISA…

Tranquis Therapeutics is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases, including ALS, using a unique immuno-neurology approach.

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing innovative therapeutics for pattern hair loss, including the investigational produ…

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

Crystalys Therapeutics is a biotechnology company specializing in the development and commercialization of therapeutic products, focusing on treatments for serious respiratory dis…

Windward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committed to transforming the treatment of people living w…

AirNexis Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies that address unmet medical needs in oncology and autoimmune disorders.

Odyssey Therapeutics is focused on transforming the standard of care for patients with autoimmune and inflammatory diseases by targeting upstream signaling nodes and mechanisms in…